Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia.
Krieger
G
G
Dept. of Hematology/Oncology, University of Göttingen, F.R.G.
Kneba
M
M
Vehmeyer
K
K
Nagel
G A
GA
Welte
K
K
D000380:Agranulocytosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004804:Eosinophils / Q000187:drug effects; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects; D008218:Lymphocytosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000473:pathology
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor